CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2012
Income Statement [Abstract]
Revenues, net			$ 28,651
Cost of Goods Sold			11,109
Gross profit			17,542
Operating Expenses:
Research and development	1,382,995	2,192,724	4,987,236
Selling and marketing			165,175
General and administrative	3,016,684	3,936,635	4,889,179
Total Operating Expenses	4,399,679	6,129,359	10,041,590
Operating Loss	(4,399,679)	(6,129,359)	(10,024,048)
Other Income (Expense):
Income from assets held for investment, net (Note 3)	193,607	1,245,165	2,206,216
Interest income	586	353	1,519
Interest expense	(321,670)	(530,222)	(592,525)
Change in fair value of derivative liabilities (Note 10)	4,525,739	(3,140,259)	(1,081,440)
Net Loss	(1,417)	(8,554,322)	(9,490,278)
Preferred Stock Dividend	2,058,329	1,722,474	376,746
Net Loss Available to Common Stockholders	$ (2,059,746)	$ (10,276,796)	$ (9,867,024)
Basic and Diluted Net Loss Per Common Share (Note 14) (in dollars per share)	$ (0.003)	$ (0.023)	$ (0.030)
Weighted Average Number of Shares of Common Stock Outstanding - basic and diluted (Note 14) (in shares)	679,630,247	443,579,247	332,333,583